INTRODUCTION
T rabeculectomywithEx-PRESSglaucomaimplantand Ahmedglaucomavalve(AGV)implantationsare surgicalproceduresthathavebeengaininginpopularityover thepastdecade [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] .TheEx-PRESSimplantisthoughtby some authorstoreducethe rateofpostoperative complicationscomparedwiththestandardtrabeculectomy, andtopossibly reducethenumberof adjunctive postoperativeglaucomamedications [1] [2] [3] [4] [5] .Howevermore recentstudiessuggestthattheEx-PRESSimplantdoesnot offerrealadvantageoverstandardtrabeculectomy [6] [7] [8] [9] [10] .An AGVisoftenusedincaseswheretheriskforfiltration failureishigh [11] . [12] [13] . [12] .Christakis [14] compared Ahmed Baerveldtglaucomadrainagedevicesover3yfor refractoryglaucoma.Bothdeviceswereeffectiveinreducing IOPandhadsimilarcomplicationrates.TheBaerveldtgroup hadlowerfailurerateandrequiredfewermedicationsthan theAhmedgroupbuttherewerealsohigherhypotonyrelated complicationsintheBaerveldtgroup. Budenz [15] recentlypublished5-yeartreatment outcomesintheAhmed-BaerveldtComparisonStudy.They foundsimilarratesofsurgicalsuccesswithbothimplants, howevertheBaerveldtproducedgreaterIOPreductionanda lowerrateofglaucomareoperationthantheAGV,butitwas alsoassociatedwithtwiceasmanyfailuresbecauseofsafety issues. Tothebestofourknowledge,thisisthefirststudy comparingdirectlybetweentrabeculectomywithEx-PRESS implantandglaucomadrainageimplant.Previousstudies showedconflictingresultswhenstandardtrabeculecomywas comparedtoAGVimplantation.Tran [16] founda significantlyhigher5-yearcumulativeprobabilityofsuccess withstandardtrabeculectomywhengreaterIOPreduction wasnecessary.Wilson [17] alsocomparedthetwo surgeriesandconcludedthatthetrabeculectomygroup achievedlowerIOPsduringthefirstyear,andthattheIOPs andthecumulativeprobabilitiesofsuccesswerecomparable afterlongerfollow-up.Shen [18] foundsimilarresults whencomparingtrabeculectomywithMMCandAGV implantationineyeswithneovascularglaucoma.Notably thesestudiesdidnot comparetrabeculectomywith Ex-PRESSimplantandhad differentpopulation characteristicscomparedtoourstudy.WhiletheTVTstudy includedcomparisonbetweenBaerveldtglaucomaimplant withstandardtrabeculectomy,ourstudyincludedonly patientswhoreceivedAGV,andcomparedthemwith trabeculectomywithEx-PRESS. Skaat [19] comparedgold-microshuntimplantsversus AGVover5y.Successratesweresimilarforbothdevices. Howevertheirstudy,similartotheTVTprotocol,excluded complicatedglaucomacasesincludingNVGanduveitic glaucoma.TheTVTstudyalsoexcludedpatientswithhistory ofpreviousdiodecyclophotocoagulation(CPC)and combinedsurgery [12] .Ourstudyaimedtoreflectthe"real world"populationsetting,andthereforethesepatient populationswerenotexcluded. TherateofmeanIOPreductioninourstudywassimilar betweengroupsandcomparabletootherstudies [3, 20] . 1 Early complications were defined as complications occurring within 1mo after surgery; 2 Late complications were defined as occurring after more than 1mo after surgery; 3 Bleb morphology was based on clinical examination by the surgeon; 4 Some patients had more than one complication. significantlyhigherfortheAGVgroupbutthisgrouphad morecomplexglaucomacaseswithhistoryofmore glaucomaandotherocularsurgeriesatbaseline.Thisstudy suggestsaplacefortheuseofbothEx-PRESSandAGVin glaucomatreatment.Furtherstudiesareneededtodefine optimalglaucomacharacteristicsfortheuseofeachdevice.
